Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 15;8(1):109.
doi: 10.1186/s13613-018-0453-z.

Artificial liver support systems: what is new over the last decade?

Juan José García Martínez  1   2 , Karim Bendjelid  3   4   5
Affiliations
Review

Artificial liver support systems: what is new over the last decade?

Juan José García Martínez et al. Ann Intensive Care. .

Abstract

The liver is a complex organ that performs vital functions of synthesis, heat production, detoxification and regulation; its failure carries a highly critical risk. At the end of the last century, some artificial liver devices began to develop with the aim of being used as supportive therapy until liver transplantation (bridge-to-transplant) or liver regeneration (bridge-to-recovery). The well-recognized devices are the Molecular Adsorbent Recirculating System™ (MARS™), the Single-Pass Albumin Dialysis system and the Fractionated Plasma Separation and Adsorption system (Prometheus™). In the following years, experimental works and early clinical applications were reported, and to date, many thousands of patients have already been treated with these devices. The ability of artificial liver support systems to replace the liver detoxification function, at least partially, has been proven, and the correction of various biochemical parameters has been demonstrated. However, the complex tasks of regulation and synthesis must be addressed through the use of bioartificial systems, which still face several developmental problems and very high production costs. Moreover, clinical data on improved survival are conflicting. This paper reviews the progress achieved and new data published on artificial liver support systems over the past decade and the prospects for these devices.

Keywords: Acute liver failure; Acute on chronic liver failure; Albumin dialysis; Artificial liver support; FPSA; MARS; Prometheus; SPAD.

PubMed Disclaimer

References

    1. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. doi: 10.1016/S0140-6736(17)32152-9. - DOI - PMC - PubMed
    1. Moreau R, Arroyo V. Acute-on-chronic liver failure: a new clinical entity. Clin Gastroenterol Hepatol. 2015;13(5):836–841. doi: 10.1016/j.cgh.2014.02.027. - DOI - PubMed
    1. Koivusalo AM, Teikari T, Hockerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis. 2008;23(4):387–398. doi: 10.1007/s11011-008-9110-9. - DOI - PubMed
    1. Guo L-MLJ-Y, Xu D-Z, Li B-S, Han H, Wang L-H, Zhang W-Y, Lu L-H, Guo X, Sun F-X, Zhang H-Y, Liu X-D, Zhang J-P, Yao Y, He Z-P, Wang M-M. Application of molecular adsorbents recirculating system to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int. 2003;23(Suppl. 3):16–20. doi: 10.1034/j.1478-3231.23.s.3.7.x. - DOI - PubMed
    1. Novelli G, Annesini MC, Morabito V, Cinti P, Pugliese F, Novelli S, et al. Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy. Transpl Proc. 2009;41(4):1243–1248. doi: 10.1016/j.transproceed.2009.03.035. - DOI - PubMed